On the other hand, previous studies have shown that circulating levels of FGF-21 are increased in pathologies such as obesity, metabolic syndrome, insulin resistance, cardiovascular disease and different chronic inflammatory processes [61]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.